Global /Taiwan /Healthcare /Drug Manufacturers - General /6659
chevron_leftBack
Timing Pharmaceutial Co.,Ltd. logo

Timing Pharmaceutial Co.,Ltd.

6659
TPEX: 6659 Delayed
20.75TWD -1.2%
0.6596 USD
As of 6 June 2026, Timing Pharmaceutial Co.,Ltd. has a market cap of $56.65M USD, ranking #29703 globally and #1763 in Taiwan. It ranks #2688 in the Healthcare sector, and #952 in the Drug Manufacturers - General industry.
Global Rank
29703
Country Rank
1763
Sector Rank
2688
Industry Rank
952
Key Stats
Market Cap
$56.65MUSD
1.78B TWD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
1968
Website
timing-pharmacy.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.2% -10% 5% -5.4% -16% -16%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
6659
ISIN: TW0006659006
Shares Out.:
85.883M1
TV:
SA:
YF:
GF:
BA:
MS:
20.75 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Timing Pharmaceutial Co.,Ltd.

Timing Pharmaceutial Co.,Ltd. manufactures and distributes medicines and biotechnological products in Taiwan and internationally. The company offers bio-tech grade herbal raw material, health supplements, beverage and tobacco, health food, K-cups, antrodia cinnamonea, natto extract, bulk herbs, chinese stewedready soup pack, essential oil patch, pain relief patch, loquat syrup, probiotics, and health care supplies. The company was founded in 1968 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)
Name
Market Cap diff.
PE
$7.8B
245.34B TWD
14K%
48.6
$1.84B
57.95B TWD
3K%
12.2
$925.55M
29.11B TWD
2K%
3.4
$809.3M
25.46B TWD
1K%
-
$789.12M
24.82B TWD
1K%
-
$584.14M
18.38B TWD
931%
11.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
1M%
38.1
JNJ
$547.28B
966K%
26.4
ABBV
$360.63B
636K%
97.4
$324.68B
256.25B CHF
573K%
19.9
AZN
$289.43B
215.59B GBP
511K%
27.6
NOVN
$277.35B
218.9B CHF
489K%
20.5
chevron_leftBack